By Judy Murrah, CIO, Applied DNA Sciences Inc
The Internet of Things is focused on smart things. “Unintelligent” things such as pharmaceuticals need a voice to ensure that they are real, safe, and traceable....
By Keith Perry, CIO & SVP, St. Jude Children's Research Hospital
It is an inspiring time to be working at the intersection of technology and health care. At St. Jude Children’s Research Hospital, we understand that technology is fundamental to accomplishing our mission.
By Joe Touey, SVP, GSK North America Pharmaceuticals IT
Many Pharma and life sciences companies consume cloud computing in the form of software-as-a-service. GSK deploys all email and collaboration technology— in the Microsoft cloud. Hence we operate in several countries with hundred thousand employees.
By Linda Shanley, VP & CIO, Saint Francis Hospital and Medical Center
I believe the patient portal has changed the patient experience. Imagine getting all your laboratory, radiology, ancillary results and clinical summary on your smart phone.
By Bijoy Sagar, Global CIO, Stryker
The medical technology industry, like many others in the healthcare sector, recognizes the importance of innovative data-based solutions in delivering a superior patient and customer experience.
By Douglas Barta, CIO, PAREXEL International
Technology plays a critical role in helping the biopharmaceutical industry navigate the complex drug development journey. There are a number of technologies available to help simplify the process, many of which can make drug development faster, more precise, trackable, and productive.
By Michael Smith, CIO & Head of Global Business Services, Mylan Bertek Pharmaceuticals
Businesses today face many obstacles that are increasingly challenging, complex and immense in scale. IT must redefine its role in business and move beyond simply being a support to organization, or we will not survive.
By Paul Kallukaran, Executive Director, Global Commercial Business Analytics
When Merck IT decided to focus on analytics, the intent was clear – empower the company to identify insights and make data-driven decisions that have the potential to solve important problems and drive shareholder value.
By Rajeev Nair, VP & CIO, Jubilant Pharma
Homogenizing and integrating the various key processes for each newly acquired entity, without compromising on the differentiation that each of them needs to strengthen their competitive advantage is a key element of the growth strategy.
By Andy Newsom, SVP, CIO, CSL Behring
The biopharmaceutical industry continues to increase its reliance on IT systems to drive business efficiencies and growth. The key to success is to build a quality focused IT foundation to ensure compliance and effectively support the business.